Loading…
Reported covered position: Dooley -D-CA
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · 3T
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Source: Senate LDA
| BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) |
| 48 |
| 2016–2026 |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | 47 | 2008–2018 |
| YAHOO MEDIA (FORMERLY REPORTING AS OATH INC AND VARIOUS SUBSIDIARIES) | 44 | 2008–2020 |
| CVS HEALTH | 42 | 2016–2026 |
| ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN) | 41 | 2013–2023 |
| FMC CORPORATION | 39 | 2014–2023 |
| PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) | 39 | 2012–2026 |
| AMERICA'S HEALTH INSURANCE PLANS (AHIP) | 37 | 2019–2026 |
| CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | 37 | 2018–2026 |
| UNUM GROUP | 37 | 2015–2026 |
| STREAMLINED SALES TAX GOVERNING BOARD, INC. | 35 | 2014–2022 |
| AMERICA'S HEALTH INSURANCE PLANS OBO COALITION AGAINST SURPRISE MEDICAL BILLING | 26 | 2021–2026 |
| ABBOTT LABORATORIES | 24 | 2021–2026 |
| VOLVO CAR CORPORATION | 24 | 2017–2022 |
| JUUL LABS | 23 | 2018–2023 |
| BIPARTISAN POLICY CENTER ADVOCACY NETWORK(FOR KNWN AS BIPARTISAN ADVOCACY CENTER | 21 | 2008–2013 |
| H-E-B GROCERY COMPANY, LP | 20 | 2022–2026 |
| CCIA (CONSUMER CREDIT INDUSTRY ASSOCIATION) | 19 | 2021–2025 |
| DIALYSIS PATIENT CITIZENS | 19 | 2018–2023 |
| NATIONAL PATIENT ADVOCATE FOUNDATION | 19 | 2010–2013 |
| REFLEXION MEDICAL | 17 | 2022–2026 |
| VARIAN MEDICAL SYSTEMS, INC. | 17 | 2008–2012 |
| NATIONAL JOB CORPS ASSOCIATON | 16 | 2017–2020 |
| ADVANCED PARTICLE THERAPY LLC (APT) | 15 | 2012–2015 |
| INTERNATIONAL FRANCHISE ASSOCIATION (IFA) | 15 | 2022–2026 |
| AMERICAN CHEMISTRY COUNCIL | 14 | 2011–2013 |
| AMERICAN CLINICAL LABORATORY ASSOCIATION | 14 | 2023–2026 |
| APOTEX, CORP. | 13 | 2024–2026 |
| ADVAMED IMAGING | 12 | 2024–2026 |
| AMERICAN SOCIETY OF TRAVEL ADVISORS (ASTA) | 12 | 2020–2023 |
| SKYSCANNER LIMITED | 12 | 2020–2022 |
| AIRBNB | 10 | 2018–2020 |
| CRICKET COMMUNICATIONS, INC. | 10 | 2008–2010 |
| NUCLEAR ENERGY INSTITUTE (NEI) | 10 | 2008–2010 |
| THE SIXTEEN THIRTY FUND | 10 | 2020–2022 |
| GROWTH ENERGY | 9 | 2009–2010 |
| Hims & Hers Health, Inc. | 8 | 2025–2026 |
| ICANN (INTERNET CORPORATION FOR ASSIGNED NAMES AND NUMBERS) | 8 | 2011–2012 |
| MCKESSON CORPORATION | 8 | 2025–2026 |
| NETFLIX INC | 8 | 2011–2012 |
| CHARTER COMMUNICATIONS OPERATING, LLC | 7 | 2021–2025 |
| CONSTELLATION ENERGY GENERATION, LLC, FORMERLY REPORTING AS EXELON CORPORATION | 7 | 2009–2010 |
| FLEX ASSOCIATION | 7 | 2022–2023 |
| NEMOURS | 7 | 2009–2011 |
| THE INTERNET ASSOCIATION | 7 | 2013–2014 |
| NATIONAL FENESTRATION RATING COUNCIL | 6 | 2008–2009 |
| TEVA PHARMACEUTICALS USA INC | 6 | 2017 |
| THE COCA-COLA COMPANY | 6 | 2025–2026 |
| ESSENTIAL MINERALS ASSOCIATION (FORMERLY REPORTING AS IMA-NA) | 5 | 2016–2017 |
| HUMANITY FORWARD | 5 | 2020–2021 |
| MERCHANT CUSTOMER EXCHANGE LLC ("MCX") | 5 | 2015–2016 |
| AMERICAN KRATOM ASSOCIATION | 4 | 2024–2026 |
| GAP INC. | 4 | 2009–2010 |
| PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) | 4 | 2026 |
| THE WEIDT GROUP | 4 | 2010 |
| TUSK PHILANTHROPIES | 4 | 2021–2022 |
| HEARTFLOW, INC. | 3 | 2026 |
| PERSONAL CARE PRODUCTS COUNCIL | 3 | 2008–2009 |
| T-MOBILE USA, INC. | 3 | 2019–2021 |
| VEMO EDUCATION | 3 | 2019 |
| CLEAN SLATE INITIATIVE, INC. (CSI) | 2 | 2024 |
| GENERAL ELECTRIC COMPANY | 2 | 2014 |
| HIGHMARK INC. | 2 | 2026 |
| HP INC | 2 | 2026 |
| HTC AMERICA, INC. | 2 | 2012–2013 |
| OPTIMUM COMMUNICATIONS (FORMERLY REPORTING AS ALTICE USA, INC.) | 2 | 2021–2024 |
| RESEARCH!AMERICA | 2 | 2023 |
| VANTIVE | 2 | 2026 |
| ANTHROPIC PBC | 1 | 2025 |
| AUCTION.COM | 1 | 2013 |
| FUELS AMERICA | 1 | 2015 |
| GLASSDOOR, INC. | 1 | 2015 |
| INVESCO HOLDING COMPANY (US), INC. | 1 | 2022 |
| SLACK TECHNOLOGIES, INC. | 1 | 2016 |
| UNITED WAY WORLDWIDE (UWW) | 1 | 2025 |
| UNIVISION COMMUNICATIONS INC. | 1 | 2016 |
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Combating Organized Retail Crime Act of 2025
Client: RETAIL INDUSTRY LEADERS ASSOCIATION (RILA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to organized retail crime, including H.R.2853, Combating Organized Retail Crime Act (CORCA).
Combating Organized Retail Crime Act of 2025
Client: GS1 US · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA) and S. 3376, The Cargo Security Innovation Act.
Combating Organized Retail Crime Act of 2025
Client: RETAIL INDUSTRY LEADERS ASSOCIATION (RILA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to organized retail crime, including H.R.2853, Combating Organized Retail Crime Act (CORCA).
Combating Organized Retail Crime Act of 2025
Client: GS1 US · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA).
Combating Organized Retail Crime Act of 2025
Client: RETAIL INDUSTRY LEADERS ASSOCIATION (RILA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to organized retail crime, including H.R.2853, Combating Organized Retail Crime Act (CORCA). Issues related to pricing.
Combating Organized Retail Crime Act of 2025
Client: GS1 US · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA) and S. 3376, The Cargo Security Innovation Act.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to S. 3525/H.R. 5267, The American Franchise Act.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
Issues related to health care and vital organ therapy. Issues related to H.R. 8319, KIDNEY Remote Monitoring Act.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA) and S. 3376, The Cargo Security Innovation Act.
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA) and S. 3376, The Cargo Security Innovation Act.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to S. 3525/H.R. 5267, The American Franchise Act.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Combating Organized Retail Crime Act of 2025
Client: GS1 US · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA).
Combating Organized Retail Crime Act of 2025
Client: RETAIL INDUSTRY LEADERS ASSOCIATION (RILA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to organized retail crime, including H.R.2853, Combating Organized Retail Crime Act (CORCA).
Combating Organized Retail Crime Act of 2025
Client: GS1 US · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA).
Combating Organized Retail Crime Act of 2025
Client: RETAIL INDUSTRY LEADERS ASSOCIATION (RILA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to organized retail crime, including H.R.2853, Combating Organized Retail Crime Act (CORCA).
Combating Organized Retail Crime Act of 2025
Client: RETAIL INDUSTRY LEADERS ASSOCIATION (RILA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to organized retail crime, including H.R.2853, Combating Organized Retail Crime Act (CORCA).
Ensuring Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to cardiovascular health. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to medical device reimbursement.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to medical device reimbursement.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to cardiovascular health. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.R.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.R.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Phasedown of Hydrofluorocarbons: Management of Certain Hydrofluorocarbons and Substitutes Under the American Innovation and Manufacturing Act of 2020".
Client: H-E-B GROCERY COMPANY LP · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Labor Relations Board relating to "Standard for Determining Joint Employer Status".
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer rule, and H.J. Res.98/S.J. Res. 49, a Congressional Review Act resolution of disapproval to overturn the National Labor Relations Board's joint employer rule.
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the National Labor Relations Board relating to "Standard for Determining Joint Employer Status".
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer rule, and H.J. Res.98/S.J. Res. 49, a Congressional Review Act resolution of disapproval to overturn the National Labor Relations Board's joint employer rule.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy including H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R.1691, The Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to appropriate reimbursement for radiopharmaceuticals.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R.1691, The Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to appropriate reimbursement for radiopharmaceuticals.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to cybersecurity. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Legislation to expand Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S.2477, the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Legislation to expand Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to cybersecurity. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.
2026 · third_quarter · Q3
Issues related to the pharmaceutical supply chain and drug shortages. Issues related to independent physician practices and community-based care.
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to access to compounded drugs and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION (RILA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to corporate taxation.
Issues related to organized retail crime, including H.R.2853, Combating Organized Retail Crime Act (CORCA). Issues related to pricing.
Issues related to the retail workforce.
Financial services, payments, competition.
Issues related to supply chains, ports and trade policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIGHMARK INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to health insurance and coverage.
Issues related to health insurance and coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to health care and vital organ therapy. Issues related to H.R. 8319, KIDNEY Remote Monitoring Act.
Filing targets: HOUSE OF REPRESENTATIVES
UNUM GROUP via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to supplemental health insurance and Family and Medical Leave.
Issues related to paid leave and retirement savings.
Filing targets: General Services Administration (GSA), SENATE
INTERNATIONAL FRANCHISE ASSOCIATION (IFA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the franchise industry.
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to S. 3525/H.R. 5267, The American Franchise Act.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the role and value of community specialty physicians.
Issues related to drug shortages and national stockpiles at the U. S. Department of War.
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Issues related to health insurance coverage. Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HP INC via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the implementation of The One Big Beautiful Bill Act (Public Law 119-21).
Issues related to manufacturing and supply chains.
Issues related to the electronics ecosystem.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H-E-B GROCERY COMPANY LP via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to payments and interchange fees.
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
Issues related to Supplemental Nutrition Assistance Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARTFLOW, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GS1 US via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the pharmaceutical supply chain.
Issues related to the health care supply chain.
Issues related to food traceability and related regulatory requirements.
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to pharmaceutical supply chains and patient access.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances. Issues related to diagnostic services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to ingredients.
Issues related to Supplemental Nutrition Assistance Program and food safety.
Issues related to environmental protection, water and recycling efforts.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICA'S HEALTH INSURANCE PLANS OBO COALITION AGAINST SURPRISE MEDICAL BILLING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to blood cancer research for adult and pediatric populations. Issues related to health coverage and patient access to care.
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency funding for medical and cancer research. Issues related to pediatric drug development. Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BEST BUY CO. INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to corporate taxation.
Issues related to global trade and supply chains.
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to tariffs and generic pharmaceuticals.
Issues related to generic pharmaceuticals and drug shortages.
Filing targets: Executive Office of the President (EOP), SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices. Issues related to FDA user fees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to clinical laboratories and payment for clinical laboratory services.
Issues related to clinical laboratories and payment for clinical laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the supply of infant formula and nutrition.
Issues related to medical device reimbursement, cybersecurity, and supply chains. Issues related to diagnostic testing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VANTIVE via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · RR
Issues related to health care and vital organ therapy.
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to corporate taxation.
Issues related to drug shortages and national stockpiles at the U. S. Department of War.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
MCKESSON CORPORATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the pharmaceutical supply chain and drug shortages. Issues related to independent physician practices and community-based care.
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIGHMARK INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · RR
Issues related to health insurance and coverage.
Issues related to health insurance and coverage.
INTERNATIONAL FRANCHISE ASSOCIATION (IFA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
Issues related to the franchise industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HP INC via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the implementation of The One Big Beautiful Bill Act (Public Law 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNUM GROUP via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to supplemental health insurance and Family and Medical Leave.
Issues related to paid leave and retirement savings.
Filing targets: General Services Administration (GSA), SENATE
AMERICAN KRATOM ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act. Issues related to the Controlled Substances Act (Public Law 91-513).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to pharmaceutical supply chains and patient access.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION (RILA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to supply chains, ports and trade policy.
Issues related to the retail workforce.
Financial services, payments, competition.
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to access to compounded drugs and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H-E-B GROCERY COMPANY LP via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
Issues related to payments and interchange fees.
Issues related to Supplemental Nutrition Assistance Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GS1 US via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA) and S. 3376, The Cargo Security Innovation Act.
Issues related to the health care supply chain.
Issues related to food traceability and related regulatory requirements.
THE COCA-COLA COMPANY via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to Supplemental Nutrition Assistance Program and food safety.
Issues related to ingredients.
Filing targets: HOUSE OF REPRESENTATIVES
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS OBO COALITION AGAINST SURPRISE MEDICAL BILLING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency funding for medical and cancer research. Issues related to pediatric drug development.
Issues related to blood cancer research for adult and pediatric populations. Issues related to health coverage and patient access to care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BEST BUY CO. INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to corporate taxation.
Issues related to global trade and supply chains.
Filing targets: U.S. Trade Representative (USTR)
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to tariffs and generic pharmaceuticals.
Issues related to generic pharmaceuticals and drug shortages.
Filing targets: Executive Office of the President (EOP), SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to health insurance coverage. Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to clinical laboratories and payment for clinical laboratory services.
Issues related to clinical laboratories and payment for clinical laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARTFLOW, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances. Issues related to diagnostic services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the supply of infant formula and nutrition.
Issues related to medical device reimbursement. Issues related to diagnostic testing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL FRANCHISE ASSOCIATION (IFA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the franchise industry.
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to consumer medical devices.
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to access to compounded drugs and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES
MCKESSON CORPORATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the pharmaceutical supply chain and drug shortages.
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Issues related to pharmaceutical supply chains and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to Supplemental Nutrition Assistance Program and food safety.
Issues related to ingredients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNUM GROUP via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to supplemental health insurance and Family and Medical Leave.
Issues related to paid leave and retirement savings.
Filing targets: General Services Administration (GSA), Treasury, Dept of
RETAIL INDUSTRY LEADERS ASSOCIATION (RILA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the retail workforce.
Financial services, payments, competition.
Issues related to supply chains, ports and trade policy.
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H-E-B GROCERY COMPANY LP via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to payments and interchange fees.
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
Filing targets: SENATE
GS1 US via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA).
Issues related to the role of global data standards in trade facilitation, customs clearance, and supply chain.
Issues related to the health care supply chain.
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to corporate taxation.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
AMERICA'S HEALTH INSURANCE PLANS OBO COALITION AGAINST SURPRISE MEDICAL BILLING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BEST BUY CO. INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to corporate taxation.
Issues related to global trade and supply chains.
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to generic pharmaceuticals and drug shortages.
Issues related to tariffs and generic pharmaceuticals.
Filing targets: SENATE
AMERICAN KRATOM ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act. Issues related to the Controlled Substances Act (Public Law 91-513).
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to health insurance coverage.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to clinical laboratories and reimbursement for clinical laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to medical device reimbursement. Issues related to diagnostic testing.
Issues related to the supply of infant formula and nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARTFLOW, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · RR
Issues related to Medicare reimbursement.
Issues related to Medicare reimbursement.
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · RR
Issues related to pharmaceutical compounding.
UNITED WAY WORLDWIDE (UWW) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the 211 network and the Human-Services Emergency Logistic Program (HELP) Act.
Issues related to the Fiscal Year 2026 appropriations process. Issues related to the lapse in federal government funding, including the Supplemental Nutrition Assistance Program (SNAP).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNUM GROUP via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to paid leave and retirement savings.
Issues related to supplemental health insurance and Family and Medical Leave.
Filing targets: General Services Administration (GSA), HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION (RILA) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to corporate taxation.
Issues related to supply chains, ports and trade policy.
Issues related to the retail workforce.
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to consumer medical devices.
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKESSON CORPORATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the pharmaceutical supply chain and drug shortages.
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANTHROPIC, PBC via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · RR
Issues relating to safety, development and use of artificial intelligence.
INTERNATIONAL FRANCHISE ASSOCIATION (IFA) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues impacting the franchise industry, including the Federal Trade Commission's Franchise Rule.
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H-E-B GROCERY COMPANY LP via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to payments and interchange fees.
Issues related to S.J.Res.14 and H.J.Res.38, providing for congressional disapproval of the rule submitted by the Environmental Protection Agency relating to the management of certain hydrofluorocarbons.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GS1 US via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the health care supply chain.
Issues related to food traceability and related regulatory requirements.
Issues related to the role of global data standards in trade facilitation, customs clearance, and supply chain.
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to Supplemental Nutrition Assistance Program and food safety.
Issues related to ingredients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Issues related to drug shortages and national stockpiles at the U. S. Department of Defense.
AMERICA'S HEALTH INSURANCE PLANS OBO COALITION AGAINST SURPRISE MEDICAL BILLING via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BEST BUY CO. INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to corporate taxation.
Issues related to global trade and supply chains.
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to generic pharmaceuticals and drug shortages.
Issues related to tariffs and generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN KRATOM ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
Issues related to Food and Drug Administration regulatory and consumer access. Issues related to the Federal Kratom Consumer Protection Act.
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to health insurance coverage.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to corporate taxation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the role of global data standards in trade facilitation, customs clearance, and supply chain.
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA) and S. 3376, The Cargo Security Innovation Act.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the role and value of community specialty physicians.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to corporate taxation.
Issues related to organized retail crime, including H.R.2853, Combating Organized Retail Crime Act (CORCA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the role of global data standards in trade facilitation, customs clearance, and supply chain.
Issues related to the pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to organized retail crime, including H.R.2853, Combating Organized Retail Crime Act (CORCA).
Issues related to corporate taxation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to food traceability and related regulatory requirements.
Issues related to the pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES
Issues related to drug shortages and national stockpiles at the U. S. Department of War.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Financial services, payments, competition.
Issues related to organized retail crime, including H.R.2853, Combating Organized Retail Crime Act (CORCA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the pharmaceutical supply chain.
Issues related to combating organized retail crime, including H.R. 2853, Combating Organized Retail Crime Act (CORCA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to corporate taxation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the Fiscal Year 2026 Agriculture-Food and Drug Administration Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE